Trader consensus on Polymarket reflects an 84.5% implied probability for no new WHO-designated COVID variant of concern before 2027, driven by the absence of any such classifications since Omicron sublineages dominated in 2023. Recent surveillance as of mid-April 2026 shows ECDC and WHO listing no variants of concern, with the spreading BA.3.2 (Cicada) subvariant—detected in over 30 countries and U.S. states—remaining a variant under monitoring due to lacking evidence of increased severity, transmissibility, or vaccine escape. High population immunity from updated vaccines and prior infections, coupled with stable wastewater trends and low hospitalization rates, underpins this positioning, though ongoing sequencing monitors for surprises ahead of 2026-27 vaccine formulations.
Polymarketデータを参照したAI生成の実験的な要約。これは取引アドバイスではなく、このマーケットの解決方法には一切関係ありません。 · 更新日はい
$235,425 Vol.
$235,425 Vol.
はい
$235,425 Vol.
$235,425 Vol.
The CDC's variant classification scheme can be found here: https://stacks.cdc.gov/view/cdc/107682.
The resolution source for this market will be official information from the CDC.
マーケット開始日: Dec 1, 2025, 4:49 PM ET
Resolver
0x65070BE91...The CDC's variant classification scheme can be found here: https://stacks.cdc.gov/view/cdc/107682.
The resolution source for this market will be official information from the CDC.
Resolver
0x65070BE91...Trader consensus on Polymarket reflects an 84.5% implied probability for no new WHO-designated COVID variant of concern before 2027, driven by the absence of any such classifications since Omicron sublineages dominated in 2023. Recent surveillance as of mid-April 2026 shows ECDC and WHO listing no variants of concern, with the spreading BA.3.2 (Cicada) subvariant—detected in over 30 countries and U.S. states—remaining a variant under monitoring due to lacking evidence of increased severity, transmissibility, or vaccine escape. High population immunity from updated vaccines and prior infections, coupled with stable wastewater trends and low hospitalization rates, underpins this positioning, though ongoing sequencing monitors for surprises ahead of 2026-27 vaccine formulations.
Polymarketデータを参照したAI生成の実験的な要約。これは取引アドバイスではなく、このマーケットの解決方法には一切関係ありません。 · 更新日
外部リンクに注意してください。
外部リンクに注意してください。
よくある質問